Fonte: Current Opinion in Lipidology. Unidade: HU
Assuntos: HIPERCOLESTEROLEMIA, ESTATINAS, ARTERIOSCLEROSE CORONÁRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MINAME, Marcio H et al. Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment. Current Opinion in Lipidology, v. 30, n. 2, p. 82-87, 2019Tradução . . Disponível em: https://doi.org/10.1097/MOL.0000000000000573. Acesso em: 10 nov. 2024.APA
Miname, M. H., Bittencourt, M. S., Nasir, K., & Santos, R. D. (2019). Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment. Current Opinion in Lipidology, 30( 2), 82-87. doi:10.1097/MOL.0000000000000573NLM
Miname MH, Bittencourt MS, Nasir K, Santos RD. Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment [Internet]. Current Opinion in Lipidology. 2019 ; 30( 2): 82-87.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1097/MOL.0000000000000573Vancouver
Miname MH, Bittencourt MS, Nasir K, Santos RD. Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment [Internet]. Current Opinion in Lipidology. 2019 ; 30( 2): 82-87.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1097/MOL.0000000000000573
